欢迎访问《中国临床药理学与治疗学》杂志官方网站,今天是 分享到:

中国临床药理学与治疗学 ›› 2006, Vol. 11 ›› Issue (12): 1380-1384.

• 研究原著 • 上一篇    下一篇

水飞蓟宾卵磷脂复合物对肝纤维化大鼠肝脏中胶原表达的影响

朱跃科, 段钟平, 朱继东1, 王宝恩2, 刘芳, 谢贤春   

  1. 首都医科大学附属北京佑安医院人工肝治疗中心, 北京 100069;
    1山东省昌乐县中医院, 昌乐 262400, 山东;
    2首都医科大学附属北京友谊医院肝病研究中心, 北京 100050
  • 收稿日期:2006-03-29 修回日期:2006-11-22 出版日期:2006-12-26 发布日期:2020-11-06
  • 作者简介:朱跃科, 男, 医学博士, 副主任医师, 主要从事肝病基础研究与临床工作。Tel:13381456223 E-mail:zhuyk126@126.com

Effects of silybin-phosphatidylcholine compound on expressions of collagens in fibrotic liver induced by dimethylnitrosamine in rats

ZHU Yue-ke, DUAN Zhong-ping, ZHU Ji-dong1, WANG Bao-en2, LIU Fang, XIE Xian-chun   

  1. Artificial Liver Center, Beijing You-an Hospital, Capital University of Medical Sciences, Beijing 100069, China;
    1Traditional Chinese Medicine Hospital of Changle County, Changle 262400, Shandong, China;
    2Liver Disease Research Center, Affiliated Youyi Hospital, Capital University of Medical Sciences, Beijing 100050, China
  • Received:2006-03-29 Revised:2006-11-22 Online:2006-12-26 Published:2020-11-06

摘要: 目的 应用二甲基亚硝胺(DMN) 建立肝纤维化大鼠模型, 研究水飞蓟宾卵磷脂复合物(SPC) 对纤维化肝组织中Ⅰ、Ⅲ型胶原表达的影响。方法 60只大鼠随机分为正常组、模型组、SPC 干预组、对照组及SPC 治疗组。采用DMN 腹腔内注射的方法建立肝纤维化大鼠模型。按6 期分类法评价各组肝纤维化程度。应用RT-PCR 检测各组肝组织中I 、III 型胶原mRNA 水平;应用免疫组织化学技术检测各组动物肝组织I 、III 型胶原的表达。结果 SPC 干预组与治疗组的大鼠肝纤维化程度、肝组织中I 型与III型胶原mRNA 水平及肝组织中I 型与III 型胶原的阳性表达均分别较模型组与模型对照组显著减轻与下降。结论 SPC 能明显减轻肝组织病理改变和肝纤维化程度, 抑制I 、III 胶原的表达是其抗肝纤维化的机制之一。

关键词: 水飞蓟宾, 胶原, 肝纤维化, 二甲基亚硝胺, 大鼠

Abstract: AIM: To investigate the effects of silybinphosphatidylcholine compound (SPC) on expressions of collagens type I and III in the fibrotic liver.METHODS: Wistar rats were randomly divided into normal control group, model group, SPC intervened group, model control group, and SPC therapeutic group.The animal models of liver fibrosis were induced by intraperitoneal injection with dimethylnitrosamine (DMN).Liver fibrosis stages were evaluated on the liver tissue sections which were performed with HE and Reticulation' s stain.Semiquantitive RT-PCR was performed to determine mRNA levels of collagens type I and III in liver tissues.Immunohistochemical staining was performed to show the positive expression of collagens type I and III in liver tissues.RESULTS: Compared with model group, liver fibrosis stage in SPC intervened grouPwas obviously lowered.Compared with model control group, the liver fibrosis was significantly relieved after SPC' s therapy.In intervened and therapeutic groups, the liver tissue' s mRNA levels of collagen type I and III were all obviously lower than those in the model and model control groups, respectively.In intervened and therapeutic groups, the positive expressions in liver tissues of collagens type I and III were all much weaker than those in the model and model control groups, respectively.CONCLUSION: Silybin has the positively preventive and therapeutic effects on the experimental liver fibrosis induced by DMN in rats, and inhibiting the expression of collagens type I and III in liver tissues is one of the anti-fibrosis mechanisms of SPC.

Key words: silybin, collagen, liver fibrosis, dimethylnitrosamine, rats

中图分类号: